203 related articles for article (PubMed ID: 19416792)
1. Plasma serotonin is a predictor for deterioration of urinary albumin excretion in men with type 2 diabetes mellitus.
Fukui M; Shiraishi E; Tanaka M; Senmaru T; Sakabe K; Harusato I; Hasegawa G; Nakamura N
Metabolism; 2009 Aug; 58(8):1076-9. PubMed ID: 19416792
[TBL] [Abstract][Full Text] [Related]
2. Low serum dehydroepiandrosterone sulfate concentration is a predictor for deterioration of urinary albumin excretion in male patients with type 2 diabetes.
Fukui M; Kitagawa Y; Kamiuchi K; Hasegawa G; Yoshikawa T; Nakamura N
Diabetes Res Clin Pract; 2006 Jul; 73(1):47-50. PubMed ID: 16413943
[TBL] [Abstract][Full Text] [Related]
3. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.
Lazarevic G; Antic S; Vlahovic P; Djordjevic V; Zvezdanovic L; Stefanovic V
Ren Fail; 2007; 29(2):199-205. PubMed ID: 17365936
[TBL] [Abstract][Full Text] [Related]
4. Association between urinary albumin excretion and plasma 5-hydroxyindole-3-acetic acid concentration in men with type 2 diabetes.
Fukui M; Ose H; Hasegawa G; Yoshikawa T; Nakamura N
Diabetes Care; 2007 Oct; 30(10):2649-51. PubMed ID: 17623827
[No Abstract] [Full Text] [Related]
5. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes.
Chuahirun T; Khanna A; Kimball K; Wesson DE
Am J Kidney Dis; 2003 Jan; 41(1):13-21. PubMed ID: 12500217
[TBL] [Abstract][Full Text] [Related]
6. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
[TBL] [Abstract][Full Text] [Related]
7. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
[TBL] [Abstract][Full Text] [Related]
8. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
Takebayashi K; Matsumoto S; Aso Y; Inukai T
J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
[TBL] [Abstract][Full Text] [Related]
9. Plasma lipoproteins and the incidence of abnormal excretion of albumin in diabetic American Indians: the Strong Heart Study.
Fagot-Campagna A; Nelson RG; Knowler WC; Pettitt DJ; Robbins DC; Go O; Welty TK; Lee ET; Howard BV
Diabetologia; 1998 Sep; 41(9):1002-9. PubMed ID: 9754817
[TBL] [Abstract][Full Text] [Related]
10. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
[TBL] [Abstract][Full Text] [Related]
11. Comparison of urinary excretion of albumin, alpha 1-microglobulin and retinol-binding protein in diabetic patients.
Galanti LM; Jamart J; Dell'omo J; Donckier J
Diabetes Metab; 1996 Oct; 22(5):324-30. PubMed ID: 8896994
[TBL] [Abstract][Full Text] [Related]
12. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus.
Takebayashi K; Suetsugu M; Wakabayashi S; Aso Y; Inukai T
Metabolism; 2007 Apr; 56(4):451-8. PubMed ID: 17378999
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 levels and albuminuria in patients with type 2 diabetes mellitus.
Zanatta CM; Gerchman F; Burttet L; Nabinger G; Jacques-Silva MC; Canani LH; Gross JL
Diabetes Res Clin Pract; 2008 May; 80(2):299-304. PubMed ID: 18346810
[TBL] [Abstract][Full Text] [Related]
14. Variability of albumin excretion in diabetes.
Dullaart RP; Roelse H; Sluiter WJ; Doorenbos H
Neth J Med; 1989 Jun; 34(5-6):287-96. PubMed ID: 2770939
[TBL] [Abstract][Full Text] [Related]
15. Intercellular adhesion molecule, plasma adiponectin and albuminuria in type 2 diabetic patients.
Lenghel AR; Kacso IM; Bondor CI; Rusu C; Rahaian R; Gherman Caprioara M
Diabetes Res Clin Pract; 2012 Jan; 95(1):55-61. PubMed ID: 21945031
[TBL] [Abstract][Full Text] [Related]
16. Retinopathy in type II diabetes mellitus associated with above-normal urinary excretion of RBP.
Holm J; Nielsen NV; Hemmingsen L
Kidney Int Suppl; 1994 Nov; 47():S105-8. PubMed ID: 7869657
[TBL] [Abstract][Full Text] [Related]
17. [Influence of glycemic blood glucose control and incipient diabetic nephropathy on the urinary excretion of N-acetyl-glucosaminidase (NAG) in diabetes mellitus].
Sánchez-Hueso MC; Mateo-Caãs J; Zamora-Madaria E
An Med Interna; 1995 May; 12(5):216-20. PubMed ID: 7669872
[TBL] [Abstract][Full Text] [Related]
18. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy.
Piwowar A; Knapik-Kordecka M; Szczecińska J; Warwas M
Diabetes Metab Res Rev; 2008 Oct; 24(7):549-53. PubMed ID: 18613218
[TBL] [Abstract][Full Text] [Related]
19. Comparison of renal resistive index among patients with Type 2 diabetes with different levels of creatinine clearance and urinary albumin excretion.
Afsar B; Elsurer R
Diabet Med; 2012 Aug; 29(8):1043-6. PubMed ID: 22269249
[TBL] [Abstract][Full Text] [Related]
20. Urinary PC-1 activity in patients with type 1 diabetes mellitus.
Stefanović V; Rajić M; Antić S; Mitić-Zlatković M; Stojiljković S; Ivić MA; Vlahović P
Ann Clin Biochem; 2003 May; 40(Pt 3):235-8. PubMed ID: 12803834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
